Genetically engineering T-cell cancer killers for acute lymphoblastic leukemia

Madely Health Headlines Commentary for February 20, 2014

Source:

‘Living drug’ kills leukemia in 88 percent of patients

Reference:

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Bitnami